APA (7th ed.) Citation

SL, C., XM, M., BJ, W., YX, Y., & HN, F. (2026). Therapeutic effects of IL-33/ST-2 pathway inhibition combined with albendazole on hepatic fibrosis and immune regulation in alveolar echinococcosis: In vivo and in vitro evidence. Parasites & vectors, 19(1), . https://doi.org/10.1186/s13071-026-07355-8

Chicago Style (17th ed.) Citation

SL, Cheng, Ma XM, Wu BJ, Yang YX, and Fan HN. "Therapeutic Effects of IL-33/ST-2 Pathway Inhibition Combined with Albendazole on Hepatic Fibrosis and Immune Regulation in Alveolar Echinococcosis: In Vivo and in Vitro Evidence." Parasites & Vectors 19, no. 1 (2026). https://doi.org/10.1186/s13071-026-07355-8.

MLA (9th ed.) Citation

SL, Cheng, et al. "Therapeutic Effects of IL-33/ST-2 Pathway Inhibition Combined with Albendazole on Hepatic Fibrosis and Immune Regulation in Alveolar Echinococcosis: In Vivo and in Vitro Evidence." Parasites & Vectors, vol. 19, no. 1, 2026, https://doi.org/10.1186/s13071-026-07355-8.